Mental Health

New Zealand based Douglas Pharmaceuticals Ltd is pleased to announce that a majority of patients with Treatment Resistant Depression experienced rapid relief of their symptoms when treated with R-107 (extended-release oral dose of ketamine) in a Phase 2 study

An eight-week programme enhancing the mental wellbeing of rangatahi in south Auckland schools is helping build confidenceand resilience in its participants

Recognising a significant gap in primary care mental health, Total Healthcare’s consultant psychiatrist David Codyre has spent 20 years creating a more holistic model that benefits GPs, nurses and their patients

Even before COVID-19 lockdowns, school closures and strict social distancing, depression was on the rise in children and teenagers around the globe

Pharmacists, as well as dishing out lotions and potions to help physical ails, frequently dispense advice on the importance of practising self-care and good mental health. But sometimes taking your own advice can be a hard pill to swallow.  

Four kaupapa Māori providers have combined as the whānau pai collaborative to offer the Mahi a Atua therapeutic approach to mental wellbeing and addiction

Pharmacists are well placed to deliver mental health interventions in their communities and a team of University of Auckland researchers are currently trying to determine how ready they are to do so

A survey by the Independent Pharmacists’ Association of New Zealand has revealed pharmacists who appear to belong to a minority group earn a significantly lower hourly rate than those who do not

Psychiatrist Caleb Armstrong believes oral ketamine does not cause hallucinations because it is absorbed more slowly than other forms of delivery 

GP researches his patients’ experiences switching from branded to generic antidepressant